Biotech · Private company
Rockwell Medical Technologies, Inc.
Track this companyFree. Adds Rockwell Medical Technologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials90 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- TrifericPhase 3 · End Stage Renal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- HeparinPhase 2 · End Stage Renal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Soluble Ferric PyrophosphatePhase 2 · End-Stage Renal Disease (ESRD)ClinicalTrials.gov · fetched Nov 12, 2026
- Standard Bicarbonate SolutionPhase 2 · End-Stage Renal Disease (ESRD)ClinicalTrials.gov · fetched Nov 12, 2026
- Fer-In-SolPhase 1 · Iron-refractory, Iron-deficiency Anemia (IRIDA)ClinicalTrials.gov · fetched Nov 12, 2026
- Shohl's solutionPhase 1 · Iron-refractory, Iron-deficiency Anemia (IRIDA)ClinicalTrials.gov · fetched Nov 12, 2026
- TrifericPhase 1 · Iron-refractory, Iron-deficiency Anemia (IRIDA)ClinicalTrials.gov · fetched Nov 12, 2026
- Triferic AVNUEnd Stage Renal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Triferic AVNU Infusion Via Freedom Pump During HemodialysisPHASE4 · COMPLETED · started Apr 19, 2021ClinicalTrials.gov NCT04689932 · fetched Nov 12, 2026
- Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)PHASE3 · UNKNOWN · started Sep 1, 2020ClinicalTrials.gov NCT04239391 · fetched Nov 12, 2026
- Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.PHASE1_PHASE2 · COMPLETED · started Jun 25, 2020ClinicalTrials.gov NCT04409132 · fetched Nov 12, 2026
- A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis PatientsPHASE1_PHASE2 · COMPLETED · started Sep 30, 2019ClinicalTrials.gov NCT04042324 · fetched Nov 12, 2026
- Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD PatientsPHASE1_PHASE2 · COMPLETED · started Oct 1, 2017ClinicalTrials.gov NCT03303144 · fetched Nov 12, 2026
- Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD PatientsPHASE1 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02739100 · fetched Nov 12, 2026
- Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy VolunteersPHASE1 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02767128 · fetched Nov 12, 2026
- Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult VolunteersPHASE1 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02636049 · fetched Nov 12, 2026
- Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic HemodialysisPHASE2 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00548249 · fetched Nov 12, 2026